Dalla Volta, A.
Palumbo, C.
Zamboni, S.
Mazziotti, G.
Triggiani, L.
Zamparini, M.
Maffezzoni, F.
Rinaudo, L.
Bergamini, M.
Di Meo, N.
Caramella, I.
Valcamonico, F.
Borghetti, P.
Guerini, A.
Farina, D.
Antonelli, A.
Simeone, C.
Berruti, A. http://orcid.org/0000-0002-3956-0043
Funding for this research was provided by:
Ferring Pharmaceuticals
UniversitĂ degli Studi di Brescia
Article History
Received: 23 April 2023
Accepted: 29 June 2023
First Online: 17 July 2023
Declarations
:
: Alberto Dalla Volta, Carlotta Palumbo, Stefania Zamboni, Gherardo Mazziotti, Luca Triggiani, Manuel Zamparini, Filippo Maffezzoni, Luca Rinaudo, Marco Bergamini, Nunzia Di Meo, Irene Caramella, Francesca Valcamonico, Paolo Borghetti, Andrea Guerini, Davide Farina, Alessandro Antonelli, Claudio Simeone and Alfredo Berruti declare that they have no conflict of interest.
: The study was carried out in accordance with the Declaration of Helsinki Principles and Good Clinical Practices and was approved by the Ethics Committee of Brescia (approval number NP2540).
: All patients provided a written informed consent.